{"id":1265,"date":"2022-12-29T08:00:00","date_gmt":"2022-12-29T08:00:00","guid":{"rendered":"https:\/\/dianhuaminglu.com\/?p=1265"},"modified":"2023-05-04T10:26:07","modified_gmt":"2023-05-04T10:26:07","slug":"%e5%90%9b%e5%ae%9e%e7%94%9f%e7%89%a9%e5%ae%a3%e5%b8%83%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb%e5%ad%a6%e6%9d%82%e5%bf%97%e3%80%8b%e5%8f%91%e8%a1%a8","status":"publish","type":"post","link":"https:\/\/dianhuaminglu.com\/%e5%90%9b%e5%ae%9e%e7%94%9f%e7%89%a9%e5%ae%a3%e5%b8%83%e3%80%8a%e6%96%b0%e8%8b%b1%e6%a0%bc%e5%85%b0%e5%8c%bb%e5%ad%a6%e6%9d%82%e5%bf%97%e3%80%8b%e5%8f%91%e8%a1%a8\/","title":{"rendered":"\u541b\u5b9e\u751f\u7269\u5ba3\u5e03\u300a\u65b0\u82f1\u683c\u5170\u533b\u5b66\u6742\u5fd7\u300b\u53d1\u8868\u53e3\u670d\u6297\u65b0\u51a0\u75c5\u6bd2\u836f\u7269VV116\u5bf9\u6bd4PAXLOVID\u6cbb\u7597\u4f34\u6709\u9ad8\u98ce\u9669\u56e0\u7d20\u7684\u8f7b\/\u4e2d\u5ea6COVID-19\u60a3\u8005III\u671f\u4e34\u5e8a\u7814\u7a76\u7ed3\u679c"},"content":{"rendered":"\n
\u5317\u4eac\u65f6\u95f42022\u5e7412\u670829\u65e5\uff0c\u5168\u7403\u6743\u5a01\u671f\u520a\u300a\u65b0\u82f1\u683c\u5170\u533b\u5b66\u6742\u5fd7\u300b\uff08The New England Journal of Medicine\uff0cNEJM<\/em>\uff0c\u5f71\u54cd\u56e0\u5b50\uff1a176.079\uff09\u5728\u7ebf\u53d1\u8868\u4e86\u541b\u5b9e\u751f\u7269\u65d7\u4e0b\u7684\u53e3\u670d\u6838\u82f7\u7c7b\u6297\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\uff08SARS-CoV-2\uff09\u836f\u7269VV116\uff08JT001\uff09\u5bf9\u6bd4\u5948\u739b\u7279\u97e6\u7247\/\u5229\u6258\u90a3\u97e6\u7247\u7ec4\u5408\u836f\u7269\uff08PAXLOVID\uff09\u7528\u4e8e\u4f34\u6709\u8fdb\u5c55\u4e3a\u91cd\u5ea6\u5305\u62ec\u6b7b\u4ea1\u9ad8\u98ce\u9669\u56e0\u7d20\u7684\u8f7b\u81f3\u4e2d\u5ea6\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u611f\u67d3\uff08COVID-19\uff09\u60a3\u8005\u65e9\u671f\u6cbb\u7597\u7684III\u671f\u4e34\u5e8a\u7814\u7a76\uff08NCT05341609\uff09\u6210\u679c \u3002\u8fd9\u662fNEJM\u53d1\u8868\u7684\u9996\u4e2a\u4e2d\u56fd\u81ea\u4e3b\u7814\u53d1\u7684\u65b0\u51a0\u521b\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n\n\n\n \u8be5\u7814\u7a76\u7531\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u745e\u91d1\u533b\u9662\u7275\u5934\u5f00\u5c55\uff0c\u662f\u5965\u5bc6\u514b\u620e\u53d8\u5f02\u682a\u6d41\u884c\u671f\u95f4\u9996\u4e2a\u9488\u5bf9\u4e2d\u56fdCOVID-19\u60a3\u8005\u5f00\u5c55\u7684\u5c0f\u5206\u5b50\u53e3\u670d\u6297\u75c5\u6bd2\u836f\u7269\u201c\u5934\u5bf9\u5934\u201dIII\u671f\u4e34\u5e8a\u7814\u7a76\u3002\u7ed3\u679c\u663e\u793a\uff0c\u7814\u7a76\u4e3b\u8981\u7ec8\u70b9\u8fbe\u5230\u8bbe\u8ba1\u7684\u975e\u52a3\u6548\u7ec8\u70b9\uff0c\u76f8\u6bd4PAXLOVID\uff0cVV116\u7ec4\u7684\u4e34\u5e8a\u6062\u590d\u65f6\u95f4\u66f4\u77ed\uff0c\u5b89\u5168\u6027\u65b9\u9762\u7684\u987e\u8651\u66f4\u5c11\u3002<\/p>\n\n\n\n \u6b64\u6b21\u53d1\u8868\u7531\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u745e\u91d1\u533b\u9662\u8d75\u4efb\u6559\u6388\u3001\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u4ec1\u6d4e\u533b\u9662\u768b\u6e90\u6559\u6388\u3001\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u745e\u91d1\u533b\u9662\u5b81\u5149\u9662\u58eb\u3001\u5f90\u61ff\u840d\u6559\u6388\u3001\u8c22\u9752\u6559\u6388\u4f5c\u4e3a\u5171\u540c\u901a\u8baf\u4f5c\u8005\uff0c\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u745e\u91d1\u533b\u9662\u66f9\u7af9\u541b\u3001\u9ad8\u536b\u76ca\u3001\u590d\u65e6\u5927\u5b66\u9644\u5c5e\u6d66\u4e1c\u533b\u9662\u5305\u7ea2\u3001\u4e0a\u6d77\u516c\u5171\u536b\u751f\u4e34\u5e8a\u4e2d\u5fc3\u51af\u6d77\u71d5\u3001\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u4ec1\u6d4e\u533b\u9662\u6885\u8212\u96c5\u4f5c\u4e3a\u5171\u540c\u7b2c\u4e00\u4f5c\u8005\u3002<\/p>\n\n\n\n \u8d75\u4efb\u6559\u6388<\/strong>\u8868\u793a\uff1a\u201c\u611f\u8c22\u60a3\u8005\u548c\u7814\u7a76\u56e2\u961f\u7684\u652f\u6301\uff0c\u8ba9\u6211\u4eec\u9ad8\u8d28\u91cf\u5730\u5b8c\u6210\u4e86\u8fd9\u9879\u4e34\u5e8a\u7814\u7a76\uff0c\u5e76\u83b7\u5f97\u56fd\u9645\u9876\u5c16\u671f\u520a\u300a\u65b0\u82f1\u683c\u5170\u533b\u5b66\u6742\u5fd7\u300b\u520a\u767b\u3002\u8be5\u7814\u7a76\u4e0d\u4ec5\u4e3a\u5168\u7403\u6297\u65b0\u51a0\u5c0f\u5206\u5b50\u836f\u7269\u7684\u4e24\u6761\u4e3b\u6d41\u5f00\u53d1\u8def\u7ebf\u2018RdRp\u6291\u5236\u5242\u2019\u548c\u20183CL\u86cb\u767d\u9176\u6291\u5236\u5242\u2019\u7684\u7814\u53d1\u548c\u4e34\u5e8a\u5e94\u7528\u63d0\u4f9b\u4e86\u5b9d\u8d35\u7684\u6570\u636e\u548c\u7ecf\u9a8c\uff0c\u66f4\u5c55\u793a\u4e86\u6211\u56fd\u81ea\u4e3b\u7814\u53d1\u7684\u6297\u65b0\u51a0\u53e3\u670d\u836f\u7269\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\u4e0ePAXLOVID\u76f8\u5f53\u3002\u671f\u5f85\u6211\u4eec\u7684\u7814\u7a76\u7ed3\u679c\u80fd\u591f\u4e3a\u6211\u56fd\u6297\u75ab\u5de5\u4f5c\u8d21\u732e\u529b\u91cf\u548c\u667a\u6167\uff01\u201d<\/p>\n\n\n\n \u541b\u5b9e\u751f\u7269\u5168\u7403\u7814\u53d1\u603b\u88c1\u90b9\u5efa\u519b\u535a\u58eb<\/strong>\u8868\u793a\uff1a\u201c\u5f53\u524d\uff0c\u75ab\u60c5\u9632\u63a7\u4f9d\u65e7\u5145\u6ee1\u6311\u6218\uff0c\u5c24\u5176\u662f\u4f34\u6709\u91cd\u75c7\u9ad8\u98ce\u9669\u56e0\u7d20\u7684\u60a3\u8005\u6cbb\u7597\uff0c\u73b0\u6709\u7597\u6cd5\u5728\u9002\u7528\u4eba\u7fa4\u5e7f\u5ea6\u3001\u53ef\u53ca\u6027\u7b49\u65b9\u9762\u4e9f\u5f85\u63d0\u5347\u3002\u8be5\u9879\u7814\u7a76\u5728NEJM\u7684\u53d1\u8868\uff0c\u8bc1\u660e\u4e86\u56fd\u9645\u5b66\u672f\u754c\u5bf9\u4e2d\u56fd\u4e13\u5bb6\u3001\u4e2d\u56fd\u5236\u836f\u4f01\u4e1a\u5171\u540c\u4e3b\u5bfc\u7684\u836f\u7269\u7684\u4e34\u5e8a\u5f00\u53d1\uff0c\u65e0\u8bba\u662f\u8bd5\u9a8c\u8bbe\u8ba1\u3001\u8bd5\u9a8c\u8d28\u91cf\u3001\u8fd8\u662f\u8bd5\u9a8c\u7ed3\u679c\uff0c\u90fd\u7ed9\u4e88\u4e86\u9ad8\u5ea6\u7684\u8ba4\u53ef\u3002\u6211\u4eec\u6b63\u5728\u6301\u7eed\u6295\u5165VV116\u5728\u5176\u4ed6\u4eba\u7fa4\u4e2d\u7684\u9002\u5e94\u75c7\u7684\u4e34\u5e8a\u5f00\u53d1\u5de5\u4f5c\uff0c\u5e0c\u671b\u80fd\u591f\u901a\u8fc7\u8fd9\u6b3e\u65b0\u7597\u6cd5\u4e3a\u6211\u56fd\u4e43\u81f3\u5168\u7403\u65b0\u51a0\u60a3\u8005\u63d0\u4f9b\u6548\u679c\u66f4\u597d\u3001\u66f4\u5b89\u5168\u7684\u6cbb\u7597\u9009\u62e9\uff01\u201d<\/p>\n\n\n\n \u76ee\u524d\uff0c\u65b0\u51a0\u75ab\u60c5\u4ecd\u7136\u5728\u5168\u7403\u8303\u56f4\u5185\u6301\u7eed\u5feb\u901f\u4f20\u64ad\uff0c\u75c5\u6bd2\u7684\u4f20\u64ad\u4e0e\u9003\u9038\u80fd\u529b\u968f\u7740\u53d8\u5f02\u4e0d\u65ad\u589e\u5f3a\u3002\u53e3\u670d\u7c7b\u6297\u75c5\u6bd2\u836f\u7269\u56e0\u5177\u6709\u7ed9\u836f\u4fbf\u5229\u3001\u8010\u836f\u5c4f\u969c\u9ad8\u3001\u8fd0\u8f93\u5b58\u50a8\u9650\u5236\u5c11\u7b49\u4f18\u52bf\uff0c\u6709\u52a9\u4e8e\u7f13\u89e3\u533b\u7597\u8d1f\u62c5\uff0c\u88ab\u8ba4\u4e3a\u662f\u6297\u75ab\u5fc5\u4e0d\u53ef\u5c11\u7684\u9632\u6cbb\u624b\u6bb5\u4e4b\u4e00\u3002\u4e0d\u8fc7\u76ee\u524d\uff0c\u4ecd\u6709\u591a\u79cd\u56e0\u7d20\u5bfc\u81f4\u836f\u7269\u7684\u5e94\u7528\u53d7\u9650\uff08\u5982\uff1a\u836f\u7269\u548c\u836f\u7269\u7684\u76f8\u4e92\u4f5c\u7528\u3001\u53ef\u53ca\u6027\u7b49\uff09\uff0c\u56e0\u6b64\u8fd8\u9700\u8981\u7814\u53d1\u66f4\u591a\u6709\u6548\u3001\u5b89\u5168\u7684\u6cbb\u7597\u836f\u7269\u3002<\/p>\n\n\n\n VV116\u662f\u4e00\u6b3e\u6211\u56fd\u81ea\u4e3b\u7814\u53d1\u7684\u53e3\u670d\u6838\u82f7\u7c7b\u6297\u75c5\u6bd2\u836f\u7269\uff0c\u53ef\u6291\u5236SARS-CoV-2\u590d\u5236\u3002\u4e34\u5e8a\u524d\u7814\u7a76\u663e\u793a\uff0cVV116\u5bf9\u65b0\u51a0\u75c5\u6bd2\u539f\u59cb\u682a\u548c\u5df2\u77e5\u7a81\u53d8\u682a\u90fd\u8868\u73b0\u51fa\u663e\u8457\u7684\u6297\u75c5\u6bd2\u4f5c\u7528\uff0c\u5e76\u5728I\u671f\u4e34\u5e8a\u7814\u7a76\u4e2d\u8868\u73b0\u51fa\u4ee4\u4eba\u6ee1\u610f\u7684\u5b89\u5168\u6027\u3001\u8010\u53d7\u6027\u548c\u836f\u4ee3\u52a8\u529b\u5b66\u6027\u8d28 \u3002\u4e00\u9879\u521d\u6b65\u7684\u5c0f\u89c4\u6a21\u7814\u7a76\u8bc1\u5b9e\uff0c\u4e0e\u5e38\u89c4\u6cbb\u7597\u76f8\u6bd4\uff0c\u5728SARS-CoV-2\u9996\u6b21\u68c0\u6d4b\u4e3a\u9633\u6027\u540e5\u5929\u5185\u63a5\u53d7VV116\u6cbb\u7597\u7684\u60a3\u8005\u7684\u6838\u9178\u8f6c\u9634\u65f6\u95f4\u66f4\u77ed \u3002<\/p>\n\n\n\n \u6b64\u6b21\u53d1\u8868\u4e3a\u4e00\u9879\u591a\u4e2d\u5fc3\u3001\u5355\u76f2\uff08\u7814\u7a76\u8005\u4fdd\u6301\u76f2\u6001\uff09\u3001\u968f\u673a\u3001\u5bf9\u7167III\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff08NCT05341609\uff09\uff0c\u4e8e2022\u5e744\u67084\u65e5\u81f35\u67082\u65e5\u671f\u95f4\uff0c\u5728\u4e0a\u6d77\u76847\u5bb6\u65b0\u51a0\u80ba\u708e\u5b9a\u70b9\u533b\u9662\u8054\u5408\u5f00\u5c55 \uff0c\u5171\u7eb3\u5165822\u4f8b\u786e\u8bca\u4e3a\u4f34\u6709\u8fdb\u5c55\u9ad8\u98ce\u9669\u7684\u8f7b\u5ea6\u81f3\u4e2d\u5ea6COVID-19\u6210\u4eba\u60a3\u8005\uff0c\u6309\u71671:1\u7684\u6bd4\u4f8b\u88ab\u5206\u914d\u81f3VV116\u7ec4\u548cPAXLOVID\u7ec4\u3002\u6700\u7ec8\uff0c\u5171\u6709771\u4f8b\uff08\u5168\u5206\u6790\u96c6\uff0cFAS\uff09\u60a3\u8005\u63a5\u53d7\u4e86VV116\uff08n=384\uff09\u6216PAXLOVID\uff08n=387\uff09\u7684\u6cbb\u7597\u3002<\/p>\n\n\n\n \u5176\u4e2d\uff0cFAS\u60a3\u8005\u7684\u4e2d\u4f4d\u5e74\u9f84\u4e3a53\u5c81\uff08\u8303\u56f4\uff1a18~94\uff09\uff0c\u5973\u6027\u5360\u6bd450.2%\uff0c\u8f7b\u75c7\u60a3\u8005\u5360\u6bd492.1%\uff0c75.7%\u7684\u60a3\u8005\u5168\u7a0b\u63a5\u79cd\u65b0\u51a0\u75ab\u82d7\u6216\u63a5\u79cd\u8fc7\u52a0\u5f3a\u9488\uff0c77.3%\u7684\u60a3\u8005\u5728\u75c7\u72b6\u51fa\u73b05\u5929\u5185\u63a5\u53d7\u4e86VV116\u6216PAXLOVID\u6cbb\u7597\u3002\u60a3\u8005\u4e2d\u6700\u5e38\u89c1\u7684\u9ad8\u98ce\u9669\u56e0\u7d20\u5305\u62ec\uff1a\u5e74\u9f84\u226560\u5c81\uff0837.7%\uff09\u3001\u5fc3\u8840\u7ba1\u75be\u75c5\uff08\u5305\u62ec\u9ad8\u8840\u538b\uff09\uff0835.1%\uff09\u3001\u80a5\u80d6\u6216\u8d85\u91cdBMI\u226525\uff0832.9%\uff09\u3001\u76ee\u524d\u5438\u70df\uff0812.5%\uff09\u548c\u7cd6\u5c3f\u75c5\uff0810.1%\uff09\u3002<\/p>\n\n\n\n \u7814\u7a76\u7684\u4e3b\u8981\u7ec8\u70b9\u662f\u4ece\u968f\u673a\u81f3\u6301\u7eed\u4e34\u5e8a\u6062\u590d\u7684\u65f6\u95f4\uff0c\u98ce\u9669\u6bd4\uff08HR\uff09\u4e24\u4fa795%\u7f6e\u4fe1\u533a\u95f4\uff08CI\uff09\u4e0b\u9650>0.8\u5b9a\u4e49\u4e3a\u975e\u52a3\u6548\u6027\u3002\u6b21\u8981\u7597\u6548\u7ec8\u70b9\u5305\u62ec\u622a\u81f3\u7b2c28\u5929\u8fdb\u5c55\u4e3a\u91cd\u5ea6\/\u5371\u91cdCOVID-19\u6216\u5168\u56e0\u6b7b\u4ea1\u7684\u60a3\u8005\u6bd4\u4f8b\uff0cCOVID-19\u76f8\u5173\u75c7\u72b6\u8bc4\u5206\u548cWHO\u4e34\u5e8a\u8fdb\u5c55\u91cf\u8868\u8bc4\u5206\u53d8\u5316\u3001\u81f3\u6301\u7eed\u75c7\u72b6\u6d88\u5931\u7684\u65f6\u95f4\u3001SARS-CoV-2\u6838\u9178\u9634\u6027\u65f6\u95f4\u7b49\u3002\u5b89\u5168\u6027\u7ec8\u70b9\u5305\u62ec\u4e0d\u826f\u4e8b\u4ef6\uff08AE\uff09\u548c\u4e25\u91cd\u4e0d\u826f\u4e8b\u4ef6\uff08SAE\uff09\u60c5\u51b5\u3002<\/p>\n\n\n\n \u6839\u636e\u6700\u7ec8\u5206\u6790\u7ed3\u679c\uff08\u622a\u81f32022\u5e748\u670818\u65e5\uff09\uff0c\u5728FAS\u4eba\u7fa4\u4e2d\uff0cVV116\u4e0ePAXLOVID\u5728\u201c\u81f3\u6301\u7eed\u4e34\u5e8a\u6062\u590d\u7684\u65f6\u95f4\u201d\u8fbe\u5230\u975e\u52a3\u6548\uff08HR=1.17\uff0c95%CI\uff1a1.02~1.36\uff09\uff0c\u4e14VV116\u7ec4\u6bd4PAXLOVID\u7ec4\u7684\u4e2d\u4f4d\u6062\u590d\u65f6\u95f4\u66f4\u77ed\uff084\u5929 vs. 5\u5929\uff09\u3002<\/p>\n\n\n\n VV116\u7ec4\u548cPAXLOVID\u7ec4\u5728\u201c\u81f3\u6301\u7eed\u75c7\u72b6\u6d88\u5931\u7684\u65f6\u95f4\u201d\u3001\u201c\u81f3\u9996\u6b21SARS-CoV-2\u6838\u9178\u9634\u6027\u65f6\u95f4\u201d\u65b9\u9762\u8868\u73b0\u7c7b\u4f3c\uff0c\u4e2d\u4f4d\u65f6\u95f4\u5747\u4e3a7\u5929\u3002\u5728\u6bcf\u4e00\u4e2a\u9884\u8bbe\u65f6\u95f4\u70b9\uff08\u7b2c5\u30017\u300110\u300114\u300128\u5929\uff09\uff0cVV116\u7ec4\u75c7\u72b6\u7f13\u89e3\u7684\u60a3\u8005\u6bd4\u4f8b\u5747\u9ad8\u4e8ePAXLOVID\u7ec4\u3002\u4e24\u7ec4\u60a3\u8005\u5747\u672a\u53d1\u751f\u8fdb\u5c55\u4e3a\u91cd\u5ea6\/\u5371\u91cdCOVID-19\u6216\u6b7b\u4ea1\u3002<\/p>\n\n\n\n \u6b64\u5916\uff0c\u672c\u7814\u7a76\u4e2d\u7ea63\/4\u7684\u60a3\u8005\u66fe\u63a5\u79cd\u8fc7\u65b0\u51a0\u75ab\u82d7\uff0c\u800c\u6b64\u7c7b\u60a3\u8005\u5728\u5927\u591a\u6570\u7684\u7814\u7a76\u4e2d\u4f1a\u88ab\u6392\u9664\u5728\u5916\uff0c\u4e9a\u7ec4\u5206\u6790\u7ed3\u679c\u663e\u793a\uff0cVV116\u548cPAXLOVID\u5728\u63a5\u79cd\u6216\u672a\u63a5\u79cd\u75ab\u82d7\u4eba\u7fa4\u4e2d\u7684\u6cbb\u7597\u7ed3\u679c\u65e0\u7edf\u8ba1\u5b66\u5dee\u5f02\u3002<\/p>\n\n\n\n \u5728\u5b89\u5168\u6027\u65b9\u9762\uff0cVV116\u6bd4PAXLOVID\u7684\u5b89\u5168\u6027\u987e\u8651\u66f4\u5c11\u3002VV116\u7ec4\u7684AE\u53d1\u751f\u7387\u4f4e\u4e8ePAXLOVID\u7ec4\uff08\u6240\u6709\u7ea7\u522b\u7684AE\uff1a67.4% vs. 77.3%\uff0c3\u62164\u7ea7AE\uff1a2.6% vs. 5.7%\uff09\u3002\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0cPAXLOVID\u4e0e\u591a\u79cd\u836f\u7269\u5b58\u5728\u76f8\u4e92\u4f5c\u7528\uff08Drug-drug interaction\uff09\uff0c\u800cVV116\u4e0d\u4f1a\u6291\u5236\u6216\u8bf1\u5bfc\u4e3b\u8981\u836f\u7269\u4ee3\u8c22\u9176\uff0c\u6216\u8005\u6291\u5236\u4e3b\u8981\u836f\u7269\u8f6c\u8fd0\u86cb\u767d\uff0c\u56e0\u6b64\u4e0e\u5408\u5e76\u7528\u836f\u53d1\u751f\u76f8\u4e92\u4f5c\u7528\u53ef\u80fd\u6027\u5c0f\u3002<\/p>\n\n\n\n <\/p>\n\n\n\n <\/p>\n\n\n\n <\/p>\n\n\n\n <\/p>\n\n\n\n <\/p>\n\n\n\n \u5173\u4e8eVV116\uff08JT001\uff09<\/strong><\/p>\n\n\n\n VV116\u662f\u4e00\u6b3e\u53e3\u670d\u6838\u82f7\u7c7b\u836f\u7269\uff0c\u53ef\u6291\u5236SARS-CoV-2\u590d\u5236\u3002\u4e34\u5e8a\u524d\u836f\u6548\u5b66\u7814\u7a76\u663e\u793a\uff0cVV116\u5728\u4f53\u5916\u5bf9\u65b0\u51a0\u75c5\u6bd2\u539f\u59cb\u682a\u548c\u5df2\u77e5\u7a81\u53d8\u682a\u90fd\u8868\u73b0\u51fa\u663e\u8457\u7684\u6297\u75c5\u6bd2\u4f5c\u7528\uff1b\u5728\u5c0f\u9f20\u6a21\u578b\u4e0a\uff0c\u4f4e\u5242\u91cf\u7684VV116\u5c31\u53ef\u5c06\u80ba\u90e8\u75c5\u6bd2\u6ef4\u5ea6\u964d\u4f4e\u81f3\u68c0\u6d4b\u9650\u4ee5\u4e0b\uff0c\u53ef\u663e\u8457\u6539\u5584\u80ba\u7ec4\u7ec7\u75c5\u7406\u53d8\u5316\uff0c\u8868\u73b0\u51fa\u8f83\u5f3a\u7684\u6297\u75c5\u6bd2\u529f\u6548\u3002\u4e34\u5e8a\u524d\u7684\u836f\u4ee3\u52a8\u529b\u5b66\u7b49\u7814\u7a76\u7ed3\u679c\u663e\u793a\uff0cVV116\u5177\u6709\u5f88\u9ad8\u7684\u53e3\u670d\u751f\u7269\u5229\u7528\u5ea6\uff0c\u5176\u53e3\u670d\u5438\u6536\u540e\uff0c\u8fc5\u901f\u4ee3\u8c22\u4e3a\u6bcd\u4f53\u6838\u82f7\uff0c\u5e76\u5728\u4f53\u5185\u7ec4\u7ec7\u5e7f\u6cdb\u5206\u5e03\u3002<\/p>\n\n\n\n VV116\u7531\u4e2d\u56fd\u79d1\u5b66\u9662\u4e0a\u6d77\u836f\u7269\u7814\u7a76\u6240\u3001\u4e2d\u56fd\u79d1\u5b66\u9662\u6b66\u6c49\u75c5\u6bd2\u7814\u7a76\u6240\u3001\u4e2d\u56fd\u79d1\u5b66\u9662\u65b0\u7586\u7406\u5316\u6280\u672f\u7814\u7a76\u6240\u3001\u4e2d\u56fd\u79d1\u5b66\u9662\u4e2d\u4e9a\u836f\u7269\u7814\u53d1\u4e2d\u5fc3\/\u4e2d\u4e4c\u533b\u836f\u79d1\u6280\u57ce\uff08\u79d1\u6280\u90e8\u201c\u4e00\u5e26\u4e00\u8def\u201d\u8054\u5408\u5b9e\u9a8c\u5ba4\uff09\u3001\u4e34\u6e2f\u5b9e\u9a8c\u5ba4\u3001\u82cf\u5dde\u65fa\u5c71\u65fa\u6c34\u751f\u7269\u533b\u836f\u6709\u9650\u516c\u53f8\uff08\u65fa\u5c71\u65fa\u6c34\uff09\u548c\u541b\u5b9e\u751f\u7269\u5171\u540c\u7814\u53d1\u3002\u541b\u5b9e\u751f\u7269\u4e0e\u65fa\u5c71\u65fa\u6c34\u5171\u540c\u627f\u62c5\u8be5\u836f\u7269\u5728\u5168\u7403\u5c42\u9762\u7684\u4e34\u5e8a\u5f00\u53d1\u548c\u4ea7\u4e1a\u5316\u5de5\u4f5c\uff0c\u5408\u4f5c\u533a\u57df\u4e3a\u9664\u4e2d\u4e9a\u4e94\u56fd\u3001\u4fc4\u7f57\u65af\u3001\u5317\u975e\u3001\u4e2d\u4e1c\u56db\u4e2a\u533a\u57df\u5916\u7684\u5168\u7403\u8303\u56f4\u3002<\/p>\n\n\n\n \u541b\u5b9e\u751f\u7269\u4e0e\u65fa\u5c71\u65fa\u6c34\u5df2\u5728\u4e2d\u56fd\u5065\u5eb7\u53d7\u8bd5\u8005\u4e2d\u5b8c\u6210\u4e863\u9879I\u671f\u7814\u7a76[1]<\/sup>\uff0c\u5e76\u5728\u4e2d\u56fd\u8f7b\/\u4e2d\u5ea6COVID-19\u9ad8\u98ce\u9669\u60a3\u8005\u4e2d\u5b8c\u62101\u9879III\u671f\u7814\u7a76[2]<\/sup>\uff08NCT05341609\uff09\uff0c\u7814\u7a76\u7ed3\u679c\u5206\u522b\u53d1\u8868\u4e8eActa Pharmacologica Sinica\u548c\u300a\u65b0\u82f1\u683c\u5170\u533b\u5b66\u6742\u5fd7\u300b\uff08The New England Journal of Medicine<\/em>\uff09\u3002<\/p>\n\n\n\n 2021\u5e74\uff0cVV116\u5728\u4e4c\u5179\u522b\u514b\u65af\u5766\u83b7\u5f97\u6279\u51c6\u7528\u4e8e\u4e2d\/\u91cd\u5ea6COVID-19\u60a3\u8005\u7684\u6cbb\u7597\u3002<\/p>\n\n\n\n <\/p>\n","protected":false},"excerpt":{"rendered":" \u5317\u4eac\u65f6\u95f42022\u5e7412\u670829\u65e5\uff0c\u5168\u7403\u6743\u5a01\u671f\u520a\u300a\u65b0\u82f1\u683c\u5170\u533b\u5b66\u6742\u5fd7\u300b\uff08The New England Journal of Medicine\uff0cNEJM\uff0c\u5f71\u54cd\u56e0\u5b50\uff1a176.079\uff09\u5728\u7ebf\u53d1\u8868\u4e86\u541b\u5b9e\u751f\u7269\u65d7\u4e0b\u7684\u53e3\u670d\u6838\u82f7\u7c7b\u6297\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\uff08SARS-CoV-2\uff09\u836f\u7269VV116\uff08JT001\uff09\u5bf9\u6bd4\u5948\u739b\u7279\u97e6\u7247\/\u5229\u6258\u90a3\u97e6\u7247\u7ec4\u5408\u836f\u7269\uff08PAXLOVID\uff09\u7528\u4e8e\u4f34\u6709\u8fdb\u5c55\u4e3a\u91cd\u5ea6\u5305\u62ec\u6b7b\u4ea1\u9ad8\u98ce\u9669\u56e0\u7d20\u7684\u8f7b\u81f3\u4e2d\u5ea6\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u611f\u67d3\uff08COVID-19\uff09\u60a3\u8005\u65e9\u671f\u6cbb\u7597\u7684III\u671f\u4e34\u5e8a\u7814\u7a76\uff08NCT05341609\uff09\u6210\u679c \u3002\u8fd9\u662fNEJM\u53d1\u8868\u7684\u9996\u4e2a\u4e2d\u56fd\u81ea\u4e3b\u7814\u53d1\u7684\u65b0\u51a0\u521b\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n","protected":false},"author":3,"featured_media":1285,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1265","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1"],"yoast_head":"\n\u53c2\u8003\u6587\u732e<\/h5>\n\n\n\n
1. Cao Z, Gao W, Bao H, et al. VV116 versus Nirmatrelvir\u2013Ritonavir for Oral Treatment of Covid-19. N Engl J Med. DOI: 10.1056\/NEJMoa2208822.
2. Qian, Hj., et al. Acta Pharmacol Sin (2022).
3. Shen Y, et al. Emerg Microbes Infect 2022;11:1518-23.
4. \u6b64\u6b21\u53c2\u4e0e\u7814\u7a76\u76847\u5bb6\u65b0\u51a0\u80ba\u708e\u5b9a\u70b9\u533b\u9662\u5206\u522b\u4e3a\uff1a\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u745e\u91d1\u533b\u9662\u3001\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u4ec1\u6d4e\u533b\u9662\u3001\u590d\u65e6\u5927\u5b66\u9644\u5c5e\u6d66\u4e1c\u533b\u9662\u3001\u4e0a\u6d77\u516c\u5171\u536b\u751f\u4e34\u5e8a\u4e2d\u5fc3\u3001\u4e0a\u6d77\u4e2d\u533b\u836f\u5927\u5b66\u9644\u5c5e\u66d9\u5149\u533b\u9662\u3001\u590d\u65e6\u5927\u5b66\u9644\u5c5e\u534e\u5c71\u533b\u9662\u3001\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u540c\u4ec1\u533b\u9662<\/strong><\/h5>\n\n\n\n1. \u672c\u6750\u6599\u65e8\u5728\u4f20\u9012\u524d\u6cbf\u4fe1\u606f\uff0c\u65e0\u610f\u5411\u60a8\u505a\u4efb\u4f55\u4ea7\u54c1\u7684\u63a8\u5e7f\uff0c\u4e0d\u4f5c\u4e3a\u4e34\u5e8a\u7528\u836f\u6307\u5bfc\u3002<\/em><\/h6>\n\n\n\n
2. \u82e5\u60a8\u60f3\u4e86\u89e3\u5177\u4f53\u75be\u75c5\u8bca\u7597\u4fe1\u606f\uff0c\u8bf7\u9075\u4ece\u533b\u7597\u536b\u751f\u4e13\u4e1a\u4eba\u58eb\u7684\u610f\u89c1\u4e0e\u6307\u5bfc\u3002<\/em><\/h6>\n\n\n\n\n\n
\u3010\u53c2\u8003\u6587\u732e\u3011<\/h5>\n\n\n\n
[1] Qian, Hj., et al. Acta Pharmacol Sin (2022).<\/h5>\n\n\n\n
[2] Cao Z, Gao W, Bao H, et al. VV116 versus Nirmatrelvir\u2013Ritonavir for Oral Treatment of Covid-19. N Engl J Med. DOI: 10.1056\/NEJMoa2208822.<\/h5>\n\n\n\n\n\n